Cargando…
Ranolazine Attenuates Brain Inflammation in a Rat Model of Type 2 Diabetes
Recent studies suggest a pathogenetic association between metabolic disturbances, including type 2 diabetes (T2DM), and cognitive decline and indicate that T2DM may represent a risk factor for Alzheimer’s disease (AD). There are a number of experimental studies presenting evidence that ranolazine, a...
Autores principales: | Cassano, Velia, Tallarico, Martina, Armentaro, Giuseppe, De Sarro, Caterina, Iannone, Michelangelo, Leo, Antonio, Citraro, Rita, Russo, Emilio, De Sarro, Giovambattista, Hribal, Marta Letizia, Sciacqua, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782607/ https://www.ncbi.nlm.nih.gov/pubmed/36555798 http://dx.doi.org/10.3390/ijms232416160 |
Ejemplares similares
-
Metabolic and Cognitive Effects of Ranolazine in Type 2 Diabetes Mellitus: Data from an in vivo Model
por: Cassano, Velia, et al.
Publicado: (2020) -
Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice
por: Roberti, Roberta, et al.
Publicado: (2021) -
Seizure susceptibility to various convulsant stimuli in the BTBR mouse model of autism spectrum disorders
por: Tallarico, Martina, et al.
Publicado: (2023) -
Audiogenic epileptic DBA/2 mice strain as a model of genetic reflex seizures and SUDEP
por: Bosco, Francesca, et al.
Publicado: (2023) -
Pediatric Drug Safety Surveillance: A 10-Year Analysis of Adverse Drug Reaction Reporting Data in Calabria, Southern Italy
por: Leporini, Christian, et al.
Publicado: (2022)